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Abstract
Background
Respiratory syncytial virus (RSV) and influenza A viruses are known to cause severe acute
respiratory tract infections (SARIs) in children. For other viruses like human rhinoviruses
(HRVs) this is less well established. Viral or bacterial co-infections are often considered
essential for severe manifestations of these virus infections.
Objective
The study aims at identifying viruses that may cause SARI in children in the absence of viral
and bacterial co-infections, at identifying disease characteristics associated with these sin-
gle virus infections, and at identifying a possible correlation between viral loads and disease
severities.
Study Design
Between April 2007 and March 2012, we identified children (<18 year) with or without a
medical history, admitted to our paediatric intensive care unit (PICU) with SARI or to the
medium care (MC) with an acute respiratory tract infection (ARTI) (controls). Data were
extracted from the clinical and laboratory databases of our tertiary care paediatric hospital.
Patient specimens were tested for fifteen respiratory viruses with real-time reverse tran-
scriptase PCR assays and we selected patients with a single virus infection only. Typical
bacterial co-infections were considered unlikely to have contributed to the PICU or MC
admission based on C-reactive protein-levels or bacteriological test results if performed.
Results
We identified 44 patients admitted to PICU with SARI and 40 patients admitted to MC with
ARTI. Twelve viruses were associated with SARI, ten of which were also associated with
ARTI in the absence of typical bacterial and viral co-infections, with RSV and HRV being the
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most frequent causes. Viral loads were not different between PICU-SARI patients and MC-
ARTI patients.
Conclusion
Both SARI and ARTI may be caused by single viral pathogens in previously healthy children
as well as in children with a medical history. No relationship between viral load and disease
severity was identified.
Introduction
Worldwide acute respiratory tract infections (ARTIs) are among the most important causes of
morbidity and mortality in children [1,2]. While most ARTIs result in relatively mild and self-
limiting disease, sometimes disease progresses to severe acute respiratory tract infections
(SARIs). SARIs are characterized by respiratory failure and are an indication for admission to a
paediatric intensive care unit (PICU) because of the need of respiratory support. Some viruses
such as respiratory syncytial virus (RSV) and influenza viruses have been shown to be the sin-
gle cause of SARI, but for other viruses like human rhinoviruses (HRVs) and human coronavi-
rus-NL63 (HCoV-NL63) this is under debate [3–5]. It may be that these viruses cause minimal
or mild disease only, but in combination with bacterial co-infections, viral co-infections or
alternatively, underlying high-risk conditions infection may result into SARI [6–8]. This
hypothesis follows observations of detection of viruses in the nasopharynx of children in
absence of clinical signs and symptoms [9–12]. Another explanation for the variable associa-
tion between infection and severe disease could be the extent of infection, as reflected by viral
loads. High viral loads may be associated with increased host cell damage and a more profound
immune response, but this relationship has not been confirmed consistently [13–15]. To
address the possible causative role of virus infections in SARIs, we performed a retrospective
study in our hospital, which has implemented routine testing for fifteen respiratory viruses
over the study period.
Materials and Methods
Patient and sample selection
We conducted a retrospective study analysing data of paediatric patients (age<18 years) with
or without a medical history that were admitted to Erasmus MC-Sophia from April 2007
through March 2012. Erasmus MC-Sophia is a tertiary paediatric referral centre. Clinical and
virological data were extracted from the clinical and laboratory databases. We collected all
qualitative and quantitative diagnostic virological data obtained with real-time reverse tran-
scriptase PCR (RT-PCR) on respiratory tract samples (nasal washing, sputum, throat swab,
nose swab, or bronchoalveolar lavage specimen (BAL)) of patients admitted to PICU or
medium care (MC). Nasal washings were obtained by infusing 1–2 ml NaCl intranasally. Sam-
ples were obtained on clinical indication. Only samples obtained upon admission or within 72
hours after admission were included. Patients could be included more than once if re-admitted
with SARI or ARTI, and a sample was obtained> 35 days after the first discharge and tested
positive for a different virus. For further analysis these patients (SARI: n = 1; ARTI: n = 1) were
considered new patients. The following clinical data was obtained: age, gender, reason for
admission, clinical diagnosis, underlying medical condition, specimen used for RT-PCR,
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C-reactive protein (CRP)-levels, bacteriological test results, types of respiratory support,
length of PICU stay and hospital stay, and final outcome. Based on this clinical data, we subse-
quently grouped patients with SARI or ARTI as primary reason for PICU or MC admission
respectively.
Patients were also categorized according to presence or absence of known risk factors for
SARI: pulmonary disease, pre-term birth (born before 37 weeks of gestation), anatomical mal-
formations, syndromal disorders, cardiovascular disease, oncology, immunology, neuro-mus-
cular impairment and other disorders including scoliosis.
Study groups
We defined SARI as a severe acute respiratory tract infection with the potential need for inva-
sive respiratory support and therefore requiring PICU admission. We defined ARTI as acute
respiratory tract infection without the need for intensive care admission and we used this
group as a control to study severe disease caused by a single virus infection. In the present
study we specifically focused on samples obtained from patients admitted to PICU or MC with
SARI or ARTI, caused by a single virus infection in the absence of typical bacterial and viral co-
infections (PICU-SARI patients and MC-ARTI patients respectively). We further defined
respiratory support into supplemental oxygen need (nasal cannula), non-invasive respiratory
support (non-rebreathing mask and optiflow), invasive respiratory support with endotracheal
intubation (nasopharyngeal tube, trachea tube, trachea-cannula) and extracorporeal mem-
brane oxygenation (ECMO).
The laboratory diagnostic work-up was RT-PCR testing for fifteen respiratory viruses: ade-
noviruses (ADV), HCoV-NL63, HCoV-OC43 and HCoV-229E, human bocavirus (HBoV),
human metapneumovirus (HMPV), influenza A and B viruses, parainfluenza viruses 1–4
(PIV), RSV type A and B and HRV [16]. Samples with a cycle threshold (Ct)-value< 40 were
considered positive. Of note Ct-values are inversely correlated to viral load, and only provide
semi-quantitative results. For the purpose of this study we combined RSV type A and B results
and we excluded patient samples obtained during an emergency department visit, out-patient-
clinic visit or from patients admitted to the neonatal intensive care unit. Positive viral test
results were traced back to patients admitted to PICU or MC. We compared all patients with a
single virus detected and admitted to PICU with patients admitted to PICU with SARI (PICU-
SARI patients), and all patients admitted to MC with patients with ARTI admitted to MC
(MC-ARTI patients).
Exclusion of typical bacterial co-infections
We excluded samples from patients with evidence of typical bacterial co-infections upon
admission and within 24 hours after admission when: CRP-levels were> 40 mg/L or tested
first time> 24 hours after admission and/or in case of positive bacteriological test results. We
defined a sputum positive for bacterial infection when> 10 bacteria per ocular field (/OF)
were present in gram staining performed on the sputum (direct examination), respiratory
pathogenic bacteria were cultured, and/or commensal bacteria were cultured with growth
of> 2 on a scale of 4. The quality of sputum was optimal for testing when it contained< 10
epithelial cells/OF (10 x 10 magnification). Sputum samples containing 10 epithelial cells/
OF observed by direct examination, were only considered sputum of good quality when the
leucocyte-to-epithelial cell ratio was 10/OF. Absence of sputum for bacteriological testing
was not a reason for exclusion, as sputum could not be obtained from all children. Further-
more, we analysed other bacterial cultures if performed and a positive culture of cerebrospinal
fluid, blood or BAL were defined as bacterial co-infection and thus a reason for exclusion from
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further analysis. Routine testing for atypical bacterial infections caused by Chlamydophila
pneumoniae,Mycoplasma pneumoniae or Bordetella pertussis was not performed.
Three investigators (FM, JVK and PF) independently reviewed the combined laboratory
and clinical data from all PICU patients, based on the previously defined selection criteria, to
decide on inclusion. Disagreement was resolved by consensus.
Statistical analyses
Data were analysed using SPSS version 20.0 (IBM, SPSS, Chicago, IL, USA) and GraphPad
Prism version 6. For continuous data, medians, interquartile ranges (IQR), lower IQR (LIQR)
and upper IQR (UIQR) were calculated. To analyse categorical data we used Fisher’s-exact
tests or Chi-square tests depending on the sample size. We calculated the number of viruses
present in the study groups. To study the relation between disease severity and viral load, we
compared the Ct-values in nasal washings in our study groups with Mann-Whitney U tests.
We only included groups with more than six children based on the following power analysis:
n = 2(2.8SD/Mean)^2, with an estimated mean of 25 and SD of 15 based on the number of
patients needed to show a difference in Ct-values.
Ethics
This study was approved by the Medical Ethical Committee of the Erasmus MC, Rotterdam
the Netherlands (MEC 2013–221). Informed consent was waived because this was a retrospec-
tive case-chart study. Data were stored anonymously and cannot be retraced to individual
patients.
Results
PICU-SARI patient characteristics
The selection of PICU-SARI patients is outlined in Fig 1 and details of excluded patients are
listed in S1 Table. An overview of the epidemiological data is shown in S1 Fig. We identified 44
PICU-SARI patients with a median age of 9.6 months (LIQR 2 -UIQR 25, min 0.46—max 152)
and an equal gender distribution (males: 22/44, 50%) (Table 1). One patient was admitted
twice because of SARI, with RSV or HRV as single causative agent detected, and with an admis-
sion interval of 23.5 months. Thirty-four patients had an underlying medical condition (34/44,
77%). The remaining ten patients were healthy until admission (10/44, 23%) (Table 1). The
most common underlying medical condition was pre-term birth (10/34, 29%). Reasons for
admission were: obstructive upper respiratory tract infection (URTI) (9/44, 20%), lower respi-
ratory tract infection (LRTI) (15/44, 34%) and severe wheezing with respiratory distress (18/
44, 41%). One patient was admitted with an apparent life-threatening event (ALTE (n = 1))
with SARI and one patient with SARI related respiratory fatigue due to muscular disease
(n = 1) (2/44, 5%). Respiratory support consisted of supplemental oxygen (9/44, 20%), non–
invasive respiratory support including non-rebreathing mask and optiflow was given in eight
patients (8/44, 18%), whereas 27 patients required invasive respiratory support (27/44, 61%).
For one patient additional ECMO was applied due to insufficient oxygenation (1/44, 2%). RSV
was more frequently detected in boys (9/13, 69%), most patients were admitted with bronchiol-
itis (10/13, 77%), six had no underlying medical condition (6/13, 46%), and eight required
invasive respiratory support (8/13, 62%). HRV was detected in six girls (6/11, 55%), most
patients were admitted with LRTI (4/11, 36%) or wheezing (4/11, 36%), all patients had an
underlying medical condition, and seven patients required invasive respiratory support (7/11,
64%). Overall, the median PICU-stay was 3 days (min 0-max 39), after which patients were
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either transferred from PICU to MC (n = 14, 32%, after which n = 8 (57%) were transferred to
another hospital or discharged n = 6 (43%)), transferred from PICU to another hospitals
(n = 22, 50%) or were discharged after PICU admission (n = 8, 18%). Admission duration in
other hospitals could not be analysed, as data was not available. The overall hospital stay for
patients admitted to both PICU and MC was 7 days (min 3-max 30). Two patients died during
PICU admission because of cardiorespiratory failure. One of these was a previously healthy
child admitted for cardiorespiratory arrest upon influenza A virus infection, the other was a
patient with spinal muscular atrophy (SMA) type-2, who developed respiratory failure due to
PIV-3.
MC-ARTI patient characteristics
The selection of MC-ARTI patients is outlined in Fig 2 and details of excluded patients are
listed in S2 Table. After using our predefined selection criteria 40 patients admitted to the MC
with ARTI were identified. The median age of the MC-ARTI patients was 14 months (LIQR
7.6 -UIQR 30, min 0.7-max 199) with more males than females (22/40, 55%) (Table 1). One
Fig 1. Flowchart patient selection for patients admitted to the paediatric intensive care unit (PICU)
with severe acute respiratory tract infections (SARIs) with one respiratory virus, in the absence of
viral co-infections and typical bacterial co-infections in children admitted to Erasmus MC-Sophia
between 2007 and 2012.
doi:10.1371/journal.pone.0150776.g001
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patient was admitted twice because of ARTI, with RSV or HMPV as single causative agent
detected, and with an admission interval of 1.4 months.
Thirty-four patients had an underlying medical condition (34/40, 85%) including: pulmo-
nary disease (5/34, 15%), a history of pre-term birth (4/34, 12%), and anatomical malforma-
tions and syndromal disorders (5/34, 15%) (Table 1). Reasons for admission were: URTI (9/40,
22.5%), LRTI (18/40, 45%) and wheezing (11/40, 27.5%). RSV was most frequently detected in
boys (7/13, 54%), most patients were admitted with bronchiolitis (7/13, 54%), ten patients had
Table 1. Baseline characteristics of children admitted to the paediatric intensive care unit (PICU) with severe acute respiratory tract infections
(SARIs) or medium care (MC) with acute respiratory tract infections (ARTIs) associated with a single virus infection in the absence of viral co-infec-
tions and typical bacterial co-infections at ErasmusMC-Sophia from 2007–2012.
PICU-SARI patients n = 44 (%) MC-ARTI patients n = 40 (%) p-values
Age
Months 9.6 (1.8–24.7, 0.46–152)a 14.15 (7.6–30.1, 0.7–199)a 0.0447
Years 0.8 (0.15–2.1, 0.04–12.7)a 1.18 (0.63–2.5, 0.06–16.6)a 0.0442
Male 22 (50) 22 (55) 0.66
Reason for Admission
Upper respiratory tract infections 9 (21) 9 (22.5)
Lower respiratory tract infections 15 (34) 18 (45)
Wheezing and oxygen need 18 (41) 11 (27.5)
Others 2 (4)* 2 (5)**
Medical history
None 10 (23) 6 (15) 0.4 (F)
Pulmonary disease (including cystic ﬁbrosis) 6 (14) 5 (12.5) ns
Pre-term birth (gestational age < 37 weeks) 10 (23) 4 (10) 0.15 (F)
Anatomical malformations and syndromal 8 (18) 5 (12.5) 0.55 (F)
Cardiovascular 1 (2) 4 (10) 0.19 (F)
Oncology and immunology - 2 (5) -
Neuro-muscular, SGA and others 9 (21) 14 (35) 0.15 (F)
Specimens
Nasal washing 34 (77) 39 (98) 0.006 (C)
Sputum 8 (18) -
Throat swab 2 (5) -
Nasal swab - 1 (2)
Respiratory support
Supplemental 9 (20) 30 (75)
Non-invasive 8 (18) 5 (12.5)
Invasive 27 (61) -
Extracorporeal oxygenation 1 (including invasive) -
None - 5 (12.5)
Length of stay
PICU stay days 3 (0–39)b 0 0.0002
Hospital stay 0 5 (1–21)b
Survival 42 (96) 39 (98) 0.61 (C)
a median, lower interquartile range—upper interquartile range, minimum-maximum
b median, minimum-maximum
* apparent life-threatening event and respiratory fatigue due to muscular disease;
** exacerbation of cystic ﬁbrosis and apparent life-threatening event; F = Fisher-exact-test C = Chi-square test.
doi:10.1371/journal.pone.0150776.t001
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underlying medical conditions (10/13, 77%), and all RSV infected patients’ required supple-
mental or non-invasive respiratory support (12/13, 92% and 1/13, 8%). HRV was mostly
detected in girls (7/12, 58%), the most common reason for admission was LRTI (7/12, 58%),
ten patients had underlying medical conditions (10/12, 83%), and nine required supplemental
oxygen (9/12, 75%), one received non-invasive respiratory support (1/12, 8%), and two HRV
infected patients did not require respiratory support (2/12, 17%). In addition, one patient was
admitted because of an exacerbation of cystic fibrosis with HRV as single pathogen detected
(1/12, 8%) and one patient was admitted with an ALTE and ARTI with also a single HRV infec-
tion (1/12, 8%). The median hospitalisation stay of MC-ARTI patients was 5 days (1–21 days).
In the MC-ARTI group one patient suffering from SMA-type 1 died with an HRV-infection.
Comparison of PICU-SARI patients with MC-ARTI patients
The median age of PICU-SARI patients was lower than for MC-ARTI patients (9.6 vs 14
months respectively; p = 0.045). Specimens tested were mainly nasal washings in both groups
Fig 2. Flowchart patient selection for patients admitted to medium care (MC) with acute respiratory
tract infections (ARTI) with one respiratory virus, in the absence of viral co-infections and typical
bacterial co-infections in children admitted to ErasmusMC-Sophia between 2007 and 2012.
doi:10.1371/journal.pone.0150776.g002
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(77% and 98%, p = 0.006). In addition, CRP-levels were similar between both groups with a
median of 6 and 7.5 mg/L respectively (p>0.05). As expected the number of bacterial sputum
samples obtained was higher in PICU-SARI patients than in MC-ARTI patients (19/44; 43% vs
8/40; 20%, p = 0.035). Overall, we found 23 patients with a single virus and a bacterial co-infec-
tion admitted to the PICU with SARI (S3 Table). Most bacterial co-infections were found in
patients with RSV (8/23, 35%) and HRV (7/23, 30%) infections. Eleven patients admitted to
the MC with ARTI had a proven bacterial co-infection (S4 Table), and PIV-3 was most fre-
quently co-detected (3/11, 27%). Due to the limited number of proven bacterial co-infections,
no associations between detected respiratory virus and bacterial infection could be evaluated.
Twenty-three percent of PICU-SARI patients were previously healthy until admission com-
pared to 15% of the MC-ARTI patients (10/44, 23% vs. 6/40, 15%, p = 0.4) (Table 1).
Detection and Distribution of Respiratory Viruses
Overall in the non selected PICU and MC patients HRV was very often detected and in a lower
percentage in samples obtained from PICU patients (31%) than in samples of MC patients
(42%) (p = 0.002), whereas RSV (24% versus 15%, p = 0.002) and ADV (10% versus 5%,
p = 0.007) were more often detected in samples obtained from PICU patients (Table 2). How-
ever, after applying our selection criteria for SARI and ARTI with a single virus only, these
Table 2. Viral pathogens detected with real time reverse transcriptase PCR in respiratory tract samples of patients admitted to the paediatric inten-
sive care unit (PICU) with or without a severe acute respiratory tact infection (SARI) andmedium care (MC) admitted patients with or without an
acute respiratory tract infection (ARTI) at the ErasmusMC-Sophia over a 5-year period (2007–2012).
Viruses PICU-SARI patients
with a single virus
and no bacterial co-
infection n = 44 (%)
All PICU
admitted
patients with a
single virus
n = 277 (%)
MC-ARTI patients
with a single virus
and no bacterial co-
infection n = 40 (%)
All MC admitted
patients with a
single virus
n = 588 (%)
p-value between
PICU-SARI
patients and
MC-ARTI patients
p-value
between all
PICU and all
MC patients
Rhinovirus 11 (25) 86 (31) 12 (30) 247 (42) 0.6 0.002
Respiratory
syncytial virus
13 (30) 65 (24) 13 (33) 86 (15) 0.8 0.002
Adenovirus 1 (2) 27 (10) - 28 (5) - 0.007
Human bocavirus 7 (16) 23 (8) 2 (5) 40 (7) 0.2 0.5
Inﬂuenza A virus 4 (9) 22 (8) 1 (3) 40 (7) 0.4 0.6
Human
metapneumovirus
1 (2) 12 (4) 3 (8) 23 (4) 0.3 0.9
Parainﬂuenzavirus
type 1
2 (5) 10 (4) 1 (2) 9 (2) ns* 0.08
Human coronavirus
OC43
1 (2) 10 (4) 2 (5) 16 (3) 0.6 0.5
Parainﬂuenzavirus
type 3
1 (2) 7 (3) 5 (13) 36 (6) 0.1 0.03
Parainﬂuenzavirus
type 4
1 (2) 6 (2) 1 (3) 13 (2) ns ns
Human coronavirus
NL63
2 (5) 5 (2) - 20 (3) - 0.3
Inﬂuenza B virus - 2 (1) - 15 (3) - 0.1
Parainﬂuenza virus
type 2
- 1 (0.4) - 7 (1) - 0.5
Human coronavirus
229E
- 1 (0.4) - 8 (1) - 0.3
* ns, not signiﬁcant.
doi:10.1371/journal.pone.0150776.t002
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differences could no longer be found. Indeed RSV and HRV were represented roughly equally
and predominated above all other viruses in both PICU-SARI patients and MC-ARTI patients
(RSV: 13/44, 30% and 13/40, 33%, HRV: 11/44, 25% and 12/40, 30%). Besides HRV and RSV
nine of the other viruses tested for were associated with SARI and seven of these viruses were
also associated with ARTI (except for ADV and HCoV-NL63). Of the ten previously healthy
PICU-SARI patients six were infected with RSV (6/10, 60%), three with HBoV (3/10, 30%),
and one was infected with influenza A virus (1/10, 10%). Of the six previously healthy
MC-ARTI patients, three patients were RSV infected (3/6, 50%), HRV was detected in two
patients (2/6, 33%) and one patient tested positive for PIV-1 (1/6, 17%).
Ct-values of viral pathogens in respiratory tract samples of PICU-SARI
patients compared to MC-ARTI patients
In an attempt to relate viral load to disease severity in PICU-SARI and MC-ARTI patients, we
compared the total combined Ct-values in nasal washings, which revealed that the median Ct-
values were not different between both groups (Ct values 22.2 vs 25.1 respectively; p = 0.191,
Fig 3). There was a difference between Ct-values of PICU-SARI patients compared to PICU-
non-SARI patients (p = 0.005). This was not found for MC-ARTI patients compared to MC-
non-ARTI patients (p = 0.0994). We also compared Ct-values of PICU-SARI patients to
MC-ARTI patients with and without a medical history and we found no differences between
the respective groups (p = 0.289 and p = 0.917, data not shown). Furthermore we compared
PICU-SARI patients with invasive respiratory support with PICU-SARI patients and
MC-ARTI patients with supplemental and non-invasive respiratory support and we found no
difference between these two groups (p = 0.0977, data not shown). Due to limited numbers we
Fig 3. Cycle threshold (Ct) values of all single virus positive samples tested in nasal washings of patients admitted to the paediatric intensive care
unit (PICU) with severe acute respiratory tract infections (SARIs) (PICU-SARI patients), all PICU admitted patients, patients admitted to medium
care (MC) with acute respiratory tract infections (ARTIs) and all MC admitted patients between 2007 and 2012. (Note: Ct-values were not available for
all samples, *with statistical significant difference).
doi:10.1371/journal.pone.0150776.g003
Respiratory Viruses and Severe Disease
PLOS ONE | DOI:10.1371/journal.pone.0150776 March 10, 2016 9 / 15
were not able to compare Ct-values for all individual viruses identified in this study, but based
on our power calculation for both RSV and HRV infected patients, sufficient samples were
available to compare Ct-values. No difference could be found in Ct-values between PICU-SARI
patients and MC-ARTI patients with median Ct-values for RSV of 20.6 vs 21.4 (p = 0.94) and
HRV with 28.3 vs 26.4 (p = 0.44) respectively (Fig 4A and 4B).
Discussion
In the present paper we have shown that in our tertiary care centre both SARI and ARTI may
be caused by single viral pathogens, with RSV and HRV being the most frequent causes. In
addition, nine others of the fifteen respiratory viruses tested for were identified as single agents
that may be associated with SARI in previously healthy children as well as in children with a
medical history. Except for ADV and HCoV-NL63, the remaining seven viruses were also asso-
ciated with ARTI in previously healthy children as well as in children with a medical history.
Our data does not support a relationship between viral load as reflected by surrogate marker
Ct-values on the one hand and disease severity reflected by MC or PICU admission on the
other. This is counter-intuitive and indeed various studies have indicated that higher viral
loads are related to more severe disease as well as locally increased cytokine production
[7,14,15,17–25]. Other studies failed to replicate this finding [11,26–29]. Our findings may
have been influenced by the selection of hospitalized and seriously ill children. Although Ct-
values as presented in our study do not represent an absolute quantitation of viral loads, we did
use these semi-quantitative values as a surrogate marker for viral load in our patient samples,
as is not unusual in this type of studies [14,20]. Moreover, viral load may be one of many fac-
tors that could be associated with disease severity. In this respect the role of a deleterious or
counter-productive immune response may be a factor related to disease severity. This has been
subject of several studies into the pathogenesis of viral respiratory disease and a better under-
standing may lead to novel targets for treatment of critically ill patients [30–38].
In accordance with several other studies, RSV and HRV were the most frequently detected
respiratory pathogens throughout the study [3,31,39,40]. RSV is a well-established respiratory
virus known to cause severe disease by itself, especially in younger children [31,39,40]. For
HRV this role as single pathogenic agent has been less well established as it is frequently
detected in combination with other respiratory viruses, and has therefore frequently been con-
sidered an innocent bystander. We described eleven critically ill patients with HRV as single
pathogen detected, supporting other studies that have described HRV as an agent that may
cause more or less severe disease [3,41,42]. Less common respiratory viruses such as HCoV
and PIV 1–4 were detected, but additional analyses were not performed due to a lack of power.
Previous studies have demonstrated a higher susceptibility to several respiratory viruses in
children with certain risk factors such as pre-term birth and broncho-pulmonary dysplasia
[39,43]. Indeed pre-term birth was also a marked factor related to hospitalization in our study.
In agreement with other studies, RSV proved to be the most common pathogen detected in
previously healthy children requiring PICU admission [39,40,44]. It is interesting to note that
HBoV and influenza A virus were also found in previously healthy PICU-SARI children. Previ-
ously we showed that also HBoV can cause SARI in paediatric patients [25]. Two of our
PICU-SARI patients died, which is comparable to previously published frequencies [2,39].
Our selection for a single virus only with an unlikely typical bacterial infection is largely
dependent on CRP-levels, which are frequently tested in clinical settings and used to help dif-
ferentiate between viral and bacterial infections [45,46]. We are aware that the low CRP-levels
( 40 mg/L) tested within 24 hours after admission used in our study, may underestimate the
occurrence of a bacterial infection or bacterial super-infection. Indeed we cannot fully exclude
Respiratory Viruses and Severe Disease
PLOS ONE | DOI:10.1371/journal.pone.0150776 March 10, 2016 10 / 15
Fig 4. A and B. Cycle threshold (Ct) values of positive samples for respiratory syncytial virus (RSV)
(A) and human rhinovirus (HRV) (B) tested in nasal washings and compared between patients
admitted to the paediatric intensive care unit (PICU) with severe acute respiratory tract infection
(SARI) (PICU-SARI patients), all PICU admitted patients, patients admitted to medium care (MC) with
acute respiratory tract infections (ARTIs) (MC-ARTI patients) and all MC admitted patients. (Note: Ct-
values were not available for all samples).
doi:10.1371/journal.pone.0150776.g004
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that some of our patients may have had secondary or pre-existing bacterial infections during
hospitalization. We can also not fully exclude the presence of atypical bacteria such asM. pneu-
moniae, C. pneumoniae or B. pertussis as these were not routinely tested for. Still, considering
the very low CRP used to include our patients, we feel that major bacterial involvement was
unlikely at the time of hospital admittance [47].
Although this is a retrospective study from one tertiary care centre only, and bacterial cul-
tures could not be performed for all patients for obvious reasons, we identified 44 PICU-SARI
patients and 40 MC-ARTI patients infected with one single virus only from a total of 3269
patient samples over a 5-year period. The data generated shed new light on the aetiological role
of several respiratory viruses: both SARI and ARTI can be caused by several single viral patho-
gens in the absence of viral and typical bacterial co-infections.
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